Cargando…
The Impact of Emerging Infectious Diseases on Chinese Blood Safety()
Emerging infectious diseases (EIDs) have always been one of the major threats to public health. Although the implementation of mandatory testing for 4 classical transfusion-transmitted infectious—human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis—has reduced the transfu...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126663/ https://www.ncbi.nlm.nih.gov/pubmed/27923518 http://dx.doi.org/10.1016/j.tmrv.2016.10.002 |
_version_ | 1783516195164520448 |
---|---|
author | He, Miao Wang, Jingxing Chen, Limin Liu, Jing Zeng, Peibin |
author_facet | He, Miao Wang, Jingxing Chen, Limin Liu, Jing Zeng, Peibin |
author_sort | He, Miao |
collection | PubMed |
description | Emerging infectious diseases (EIDs) have always been one of the major threats to public health. Although the implementation of mandatory testing for 4 classical transfusion-transmitted infectious—human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis—has reduced the transfusion risk of these pathogens, the potential threat of various EID agents and their constantly evolving variants to blood safety in China is not fully understood. This review presents 9 representative EID agents that are autochthonous and epidemic nationally or regionally in China. The epidemiologic status and distribution of these EID agents among donors and/or healthy populations are summarized. The potential risks of these EID agents to blood safety are discussed. The review also explores strategies to strengthen hemovigilance systems and studies to further evaluate the impact of EID agents on blood safety. |
format | Online Article Text |
id | pubmed-7126663 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71266632020-04-08 The Impact of Emerging Infectious Diseases on Chinese Blood Safety() He, Miao Wang, Jingxing Chen, Limin Liu, Jing Zeng, Peibin Transfus Med Rev Special Issue Article Emerging infectious diseases (EIDs) have always been one of the major threats to public health. Although the implementation of mandatory testing for 4 classical transfusion-transmitted infectious—human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis—has reduced the transfusion risk of these pathogens, the potential threat of various EID agents and their constantly evolving variants to blood safety in China is not fully understood. This review presents 9 representative EID agents that are autochthonous and epidemic nationally or regionally in China. The epidemiologic status and distribution of these EID agents among donors and/or healthy populations are summarized. The potential risks of these EID agents to blood safety are discussed. The review also explores strategies to strengthen hemovigilance systems and studies to further evaluate the impact of EID agents on blood safety. Elsevier Inc. 2017-04 2016-11-04 /pmc/articles/PMC7126663/ /pubmed/27923518 http://dx.doi.org/10.1016/j.tmrv.2016.10.002 Text en © 2016 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Special Issue Article He, Miao Wang, Jingxing Chen, Limin Liu, Jing Zeng, Peibin The Impact of Emerging Infectious Diseases on Chinese Blood Safety() |
title | The Impact of Emerging Infectious Diseases on Chinese Blood Safety() |
title_full | The Impact of Emerging Infectious Diseases on Chinese Blood Safety() |
title_fullStr | The Impact of Emerging Infectious Diseases on Chinese Blood Safety() |
title_full_unstemmed | The Impact of Emerging Infectious Diseases on Chinese Blood Safety() |
title_short | The Impact of Emerging Infectious Diseases on Chinese Blood Safety() |
title_sort | impact of emerging infectious diseases on chinese blood safety() |
topic | Special Issue Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7126663/ https://www.ncbi.nlm.nih.gov/pubmed/27923518 http://dx.doi.org/10.1016/j.tmrv.2016.10.002 |
work_keys_str_mv | AT hemiao theimpactofemerginginfectiousdiseasesonchinesebloodsafety AT wangjingxing theimpactofemerginginfectiousdiseasesonchinesebloodsafety AT chenlimin theimpactofemerginginfectiousdiseasesonchinesebloodsafety AT liujing theimpactofemerginginfectiousdiseasesonchinesebloodsafety AT zengpeibin theimpactofemerginginfectiousdiseasesonchinesebloodsafety AT hemiao impactofemerginginfectiousdiseasesonchinesebloodsafety AT wangjingxing impactofemerginginfectiousdiseasesonchinesebloodsafety AT chenlimin impactofemerginginfectiousdiseasesonchinesebloodsafety AT liujing impactofemerginginfectiousdiseasesonchinesebloodsafety AT zengpeibin impactofemerginginfectiousdiseasesonchinesebloodsafety |